Dassault Systèmes: investment in BioSerenity

(CercleFinance.com) - Late on Tuesday Dassault Systèmes announced its participation, as a major investor in a 65 million euro Series B financing in BioSerenity, a startup specialising in the development of complete textile medical devices carrying sensors and telehealth services online, for the diagnosis and monitoring of chronic diseases.


Three of the startup's historical investors - BPI, Idinvest and LBO - also participated in the deal.

"The funds will be used to further develop BioSerenity's solutions beyond their initial focus on cardiovascular, neurology and sleep disorders, to grow its business internationally, and to develop new solutions for telemedicine," Dassault Systèmes said.


Copyright (c) 2019 CercleFinance.com. All rights reserved.